Chemotherapy for malignant melanoma: combinations and high doses produce more responses without survival benefit.

In a consecutive series of studies, 164 patients with symptomatic and/or visceral metastatic malignant melanoma were treated with single agent vindesine, high dose melphalan with autologous bone marrow transplantation (AMBT), high dose BCNU with ABMT or the BOLD (bleomycin, vincristine, CCNU and DTI...

Descripción completa

Detalles Bibliográficos
Autores principales: Lakhani, S., Selby, P., Bliss, J. M., Perren, T. J., Gore, M. E., McElwain, T. J.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1990
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971420/
https://www.ncbi.nlm.nih.gov/pubmed/1690022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971420/
https://www.ncbi.nlm.nih.gov/pubmed/1690022

Ejemplares similares